Terms: = Thyroid cancer AND RET, RET51, 5979, P07949, ENSG00000165731, MTC1, MEN2A, RET-ELE1, HSCR1, MEN2B, CDHF12 AND Prognosis
261 results:
1. Integrated proteogenomic and metabolomic characterization of papillary thyroid cancer with different recurrence risks.
Qu N; Chen D; Ma B; Zhang L; Wang Q; Wang Y; Wang H; Ni Z; Wang W; Liao T; Xiang J; Wang Y; Jin S; Xue D; Wu W; Wang Y; Ji Q; He H; Piao HL; Shi R
Nat Commun; 2024 Apr; 15(1):3175. PubMed ID: 38609408
[TBL] [Abstract] [Full Text] [Related]
2. Advances in targeted therapy and biomarker research in thyroid cancer.
Guo M; Sun Y; Wei Y; Xu J; Zhang C
Front Endocrinol (Lausanne); 2024; 15():1372553. PubMed ID: 38501105
[TBL] [Abstract] [Full Text] [Related]
3. Updates on the genetics of multiple endocrine neoplasia.
Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
[TBL] [Abstract] [Full Text] [Related]
4. Clinical value of multi-gene testing in distinguishing benign and malignant thyroid nodules.
Zhang M; Hu X; Liu L; Wang Y; Jiang J; Li H; Fei W; Zhong T; Jiang Z
Medicine (Baltimore); 2024 Jan; 103(4):e35960. PubMed ID: 38277563
[TBL] [Abstract] [Full Text] [Related]
5. [Precision medicine in endocrinology exemplified by medullary thyroid cancer].
Brandenburg T; Machlah YM; Führer D
Inn Med (Heidelb); 2024 Mar; 65(3):202-210. PubMed ID: 38231404
[TBL] [Abstract] [Full Text] [Related]
6. Artificial Intelligence Detected the Relationship Between Nuclear Morphological Features and Molecular Abnormalities of Papillary thyroid Carcinoma.
Nishikawa T; Matsuzaki I; Takahashi A; Ryuta I; Musangile FY; Sagan K; Nishikawa M; Mikasa Y; Takahashi Y; Kojima F; Murata SI
Endocr Pathol; 2024 Mar; 35(1):40-50. PubMed ID: 38165630
[TBL] [Abstract] [Full Text] [Related]
7. Modeling ret-Rearranged Non-Small Cell Lung cancer (NSCLC): Generation of Lung Progenitor Cells (LPCs) from Patient-Derived Induced Pluripotent Stem Cells (iPSCs).
Marcoux P; Hwang JW; Desterke C; Imeri J; Bennaceur-Griscelli A; Turhan AG
Cells; 2023 Dec; 12(24):. PubMed ID: 38132167
[TBL] [Abstract] [Full Text] [Related]
8. The Clinical Utility of Gallium-68-DOTATATE Positron Emission Tomography Scanning in Medullary thyroid cancer.
Gild ML; Kumar S; Fuchs TL; Glover A; Sidhu S; Sywak M; Tsang V; Gill AJ; Robinson BG; Schembri G; Clifton-Bligh RJ; Hoang J
Endocr Pract; 2024 Mar; 30(3):218-224. PubMed ID: 38103829
[TBL] [Abstract] [Full Text] [Related]
9. ret fusion genes in pediatric and adult thyroid carcinomas: cohort characteristics and prognosis.
Bulanova Pekova B; Sykorova V; Mastnikova K; Vaclavikova E; Moravcova J; Vlcek P; Lancova L; Lastuvka P; Katra R; Bavor P; Kodetova D; Chovanec M; Drozenova J; Matej R; Astl J; Hlozek J; Hrabal P; Vcelak J; Bendlova B
Endocr Relat Cancer; 2023 Dec; 30(12):. PubMed ID: 37882481
[TBL] [Abstract] [Full Text] [Related]
10. Genetic alterations landscape in paediatric thyroid tumours and/or differentiated thyroid cancer: Systematic review.
de Sousa MSA; Nunes IN; Christiano YP; Sisdelli L; Cerutti JM
Rev Endocr Metab Disord; 2024 Feb; 25(1):35-51. PubMed ID: 37874477
[TBL] [Abstract] [Full Text] [Related]
11. Association of the Genomic Profile of Medullary thyroid Carcinoma with Tumor Characteristics and Clinical Outcomes in an International Multicenter Study.
Xu B; Viswanathan K; Ahadi MS; Ahmadi S; Alzumaili B; Bani MA; Baudin E; Behrman DB; Capelletti M; Chau NG; Chiarucci F; Chou A; Clifton-Bligh R; Coluccelli S; de Biase D; De Leo A; Dogan S; Fagin JA; Fuchs TL; Glover AR; Hadoux J; Lacroix L; Lamartina L; Lubin DJ; Luxford C; Magliocca K; Maloberti T; Mohanty AS; Najdawi F; Nigam A; Papachristos AJ; Repaci A; Robinson B; Scoazec JY; Shi Q; Sidhu S; Solaroli E; Sywak M; Tuttle RM; Untch B; Barletta JA; Al Ghuzlan A; Gill AJ; Ghossein R; Tallini G; Ganly I
Thyroid; 2024 Feb; 34(2):167-176. PubMed ID: 37842841
[No Abstract] [Full Text] [Related]
12. Targeting the ret tyrosine kinase in neuroblastoma: A review and application of a novel selective drug design strategy.
Steen EA; Basilaia M; Kim W; Getz T; Gustafson JL; Zage PE
Biochem Pharmacol; 2023 Oct; 216():115751. PubMed ID: 37595672
[TBL] [Abstract] [Full Text] [Related]
13. Review article: new treatments for advanced differentiated thyroid cancers and potential mechanisms of drug resistance.
Hamidi S; Hofmann MC; Iyer PC; Cabanillas ME; Hu MI; Busaidy NL; Dadu R
Front Endocrinol (Lausanne); 2023; 14():1176731. PubMed ID: 37435488
[TBL] [Abstract] [Full Text] [Related]
14. Clinical Characteristics and Responses to Immune Checkpoint Inhibitors in ret-Aberrant Digestive Tract Tumours.
Yen CC; Yeh YM; Huang HY; Ting YL; Fu PA; Lin TC; Liu IT; Yen CJ
Target Oncol; 2023 Jul; 18(4):611-623. PubMed ID: 37347391
[TBL] [Abstract] [Full Text] [Related]
15. Medullary thyroid cancer: Updates and Challenges.
Gild ML; Clifton-Bligh RJ; Wirth LJ; Robinson BG
Endocr Rev; 2023 Sep; 44(5):934-946. PubMed ID: 37204852
[TBL] [Abstract] [Full Text] [Related]
16. Looking for ret alterations in thyroid cancer: clinical relevance, methodology and timing.
Elisei R; Romei C
Endocrine; 2023 Aug; 81(2):206-215. PubMed ID: 37195581
[TBL] [Abstract] [Full Text] [Related]
17. Molecular and clinical features of papillary thyroid cancer in adult patients with a non-classical phenotype.
Zhou J; Wang WR; Zhang HF; Gao QQ; Wang WB; Zhu JH; Han YS; Chen J; Ma TH; Zhang XY; Teng XD
Front Endocrinol (Lausanne); 2023; 14():1138100. PubMed ID: 37124750
[TBL] [Abstract] [Full Text] [Related]
18. Papillary thyroid carcinoma with aggressive fused follicular and solid growth pattern: A unique histological subtype with high-grade malignancy?
Murata SI; Matsuzaki I; Kishimoto M; Katsuki N; Onishi T; Hirokawa M; Kojima F
Pathol Int; 2023 May; 73(5):207-211. PubMed ID: 37042564
[TBL] [Abstract] [Full Text] [Related]
19. Diffuse sclerosing variant papillary thyroid carcinoma has worse survival than classic papillary thyroid carcinoma: a meta-analysis.
Crayton H; Wu K; Leong D; Bhimani N; Gild M; Glover A
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36952650
[TBL] [Abstract] [Full Text] [Related]
20. Multi-omics profiling of papillary thyroid microcarcinoma reveals different somatic mutations and a unique transcriptomic signature.
Li Q; Feng T; Zhu T; Zhang W; Qian Y; Zhang H; Zheng X; Li D; Yun X; Zhao J; Li Y; Yu H; Gao M; Qian B
J Transl Med; 2023 Mar; 21(1):206. PubMed ID: 36941725
[TBL] [Abstract] [Full Text] [Related]
[Next]